Geben Sie eine Aktie oder eine Kryptowährung in der Suchleiste an, um eine Zusammenfassung zu erhalten
Purapharm Corp Ltd
1498PuraPharm Corporation Limited, an investment holding company, engages in research, development, production, and sale of concentrated Chinese medicine granule (CCMG) and Chinese healthcare products in Hong Kong, Mainland China, and internationally. It operates through five segments: China CCMG, Hong Kong CCMG, Chinese Healthcare Products, Clinics, and Plantation. The company offers over the counter health products under the PuraGold, Oncozac, Haveron, and Immuzac brand names. It also provides Chinese medicine clinic management system for general clinic management; and operates Chinese medicine clinics under the Nong's name that provide Chinese medicine services and CCMG products. In addition, the company engages in the plantation and trading of raw Chinese herbs; manufacture and sale of traditional Chinese medicine decoction pieces; provision of modernized Chinese medicine services, Chinese medical diagnostic, and marketing consultation services; and research and development of bio-based polymeric materials. The company sells its products to hospitals, healthcare institutions, mobile clinics, and medicine practitioners, as well as operates an online platform. The company was founded in 1998 and is headquartered in Tai Po, Hong Kong. Address: Wireless Centre, Phase One, Tai Po, Hong Kong
Analytics
Zielpreis von Wall Street
32.68 HKDKGV
–Dividendenrendite
–Laufendes Jahr
Letztes Jahr
Laufendes Quartal
Letztes Quartal
Laufendes Jahr
Letztes Jahr
Laufendes Quartal
Letztes Quartal
Schlüsselzahlen 1498
Dividenden-Analyse 1498
Dividendenwachstum über 5 Jahre
–Kontinuierliches Wachstum
–Ausschüttungsquote 5-Jahres-Durchschnitt
–Verlauf der Dividende 1498
Bewertung der Aktie 1498
Finanzen 1498
Ergebnisse | 2019 | Dynamik |